RB

Ravi Burman

Active Director Director DIN 10903230
DIN 10903230 First appointment Jan 2025 Primary industry Home Appliances
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value •••• Premium profile

About Ravi Burman

Data last updated:

Ravi Burman is a Director at Adoshine Pharmaceuticals Private Limited (since 2025). The company operates in Home Appliances. Adoshine Pharmaceuticals Private Limited reported revenue of ₹1.3 Lakh (FY 2025).

DIN 10903230
Primary Designation Director
Industry Home Appliances
First Appointment 13 Jan 2025
Oldest Company Age 3 yrs
Largest company Adoshine Pharmaceuticals Private Limited · ₹1.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Jan 20252022₹1.3 Lakh (FY 2025)Active

Board colleagues of Ravi Burman

NameDINCompanyDesignation
Aditya Kumar09803045Adoshine Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Adoshine Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ravi Burman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Burman

Ravi Burman currently holds 1 directorship: Adoshine Pharmaceuticals Private Limited (Director, since 13 Jan 2025, revenue ₹1.3 Lakh (FY 2025)).

Ravi Burman was first appointed on 13 Jan 2025 as Director at Adoshine Pharmaceuticals Private Limited.

The current boards of Ravi Burman's companies include Aditya Kumar (Adoshine Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available